DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Chow R, Chiu L, Herrstedt J. et al
Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patients.

Support Care Cancer 2021;
29 (08) 4269-4275

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: